Positions

Overview

  • Dr. McCarty is a physician in Infectious Diseases at the University of Alabama at Birmingham and the Birmingham Veterans Affairs Medical Center (BVAMC). He also serves as co-director of antimicrobial stewardship at the BVAMC. Dr. McCarty's research interests include transplant infectious diseases, fungal infections, and antimicrobial stewardship.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2023 Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals.  Clinical Infectious Diseases.  76:229-237. 2023
    2023 Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial 2023
    2023 Test Performance and Potential Clinical Utility of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel.  Microbiology Spectrum.  11. 2023
    2022 Analytical performance and potential clinical utility of the GenMark Dx ePlex® blood culture identification gram-positive panel.  Diagnostic Microbiology and Infectious Disease.  104. 2022
    2022 Management of Histoplasmosis by Infectious Disease Physicians.  Open Forum Infectious Diseases.  9. 2022
    2022 Clinical utility of antifungal susceptibility testing.  JAC-Antimicrobial Resistance.  4. 2022
    2022 #SoMe the Money! Value, Strategy, and Implementation of Social Media Engagement for Infectious Diseases Trainees, Clinicians, and Divisions.  Clinical Infectious Diseases.  74:S229-S236. 2022
    2022 Educational Impact of #IDJClub, a Twitter-Based Infectious Diseases Journal Club.  Clinical Infectious Diseases.  74:S244-S250. 2022
    2022 The Digital Classroom: How to Leverage Social Media for Infectious Diseases Education.  Clinical Infectious Diseases.  74:S237-S243. 2022
    2022 Candidemia and Severe Coronavirus Disease 2019: Which Risk Factors Are Modifiable?.  Clinical Infectious Diseases.  74:812-813. 2022
    2022 Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.  Lancet Infectious Diseases.  22:401-412. 2022
    2022 Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic.  American Journal of Transplantation.  22:279-288. 2022
    2021 Antifungal Pipeline.  Frontiers in Cellular and Infection Microbiology.  11. 2021
    2021 Candidemia and Invasive Candidiasis.  Infectious Disease Clinics of North America.  35:389-413. 2021
    2021 Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency.  Cell Reports Medicine.  2. 2021
    2021 Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study.  Clinical Infectious Diseases.  73:E4090-E4099. 2021
    2020 Reply to Tascini et al.  Clinical Infectious Diseases.  70:1523-1524. 2020
    2019 Impact of infectious disease consultation on clinical management and mortality in patients with candidemia.  Clinical Infectious Diseases.  68:1585-1587. 2019
    2019 Amphotericin B induction with voriconazole consolidation as salvage therapy for FKS-associated echinocandin resistance in Candida glabrata septic arthritis and osteomyelitis.  Antimicrobial Agents and Chemotherapy.  63. 2019
    2018 Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experience.  Infection Control and Hospital Epidemiology.  39:1419-1424. 2018
    2018 Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: Analysis of trends and outcomes.  Journal of Antimicrobial Chemotherapy.  73:1677-1680. 2018
    2016 Invasive Candidiasis.  Infectious Disease Clinics of North America.  30:103-124. 2016
    2015 Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET).  Medical Mycology.  53:440-446. 2015
    2015 Cytomegalovirus appendicitis in solid organ transplant patients, two cases and a review.  Journal of Clinical Virology.  66:48-50. 2015
    2014 The Evolving Epidemiology of Sporotrichosis.  Current Fungal Infection Reports.  8:255-261. 2014
    2011 Discussion.  Annals of Thoracic Surgery.  91:1700-1701. 2011

    Principal Investigator On

    Investigator On

  • (CSSC-001) Convalescent Plasma to Stem Coronavirus: A Randomized Controlled Double Blinded Phase 2 Study Comparing the Efficacy and Safety of Human Coronavirus Immune Plasma (HCIP) vs. control( SARS-CoV-2 non-immune plasma) among Adults Exposed to COVID-19 and (CSSC-004) Convalescent Plasma to Stem Coronavirus: A Randomized Controlled Double Blinded Phase 2 Study Comparing the Efficacy and Safety of Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 non-immune plasma)  awarded by Johns Hopkins University
  • A Phase 2/3 Open-label, Randomized, Sequential Dose Escalation Cohort Study of T2307 Versus Standard of Care in Treatment of Subjects with Candidemia due to Candida Auris and other Drug-resistant Candida Species: An Adaptive Design Study  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • A Prospective Cohort Study of Cryptococcus  awarded by Johns Hopkins University
  • B Cell Subsets and Infectious Immunity to Cryptococcosis  awarded by ALBERT EINSTEIN COLLEGE OF MEDICINE
  • COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)  awarded by CDC - Centers for Disease Control and Prevention/DHHS
  • Convalescent Plasma Randomized Clinical Trials for SARS-CoV-2 Prophylaxis and Early COVID-19 Treatment are Foundational for Subsequent Hyperimmune Globulin and Vaccines  awarded by Johns Hopkins University
  • High VS. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients  awarded by VANDERBILT UNIVERSITY
  • Improving Clinical and Public Health Outcomes through National Partnerships to Prevent and Control Emerging and Re-Emerging Infectious Disease Threats  awarded by CDC - Centers for Disease Control and Prevention/DHHS
  • Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) COVID 19 SUPPLEMENT  awarded by Emory University
  • Phase II Multi-Center, Prospective, Randomized, Double-Blind Study of Nitazoxanide in Acute and Chronic Norovirus in Hematpoietic Stem Cell and Solid Organ Transplant Recipients  awarded by Northwestern University
  • Private Grant  awarded by MERCK SHARP & DOHME CORP
  • Private Grant  awarded by MERCK SHARP & DOHME CORP
  • Private Grant  awarded by CUBIST PHARMACEUTICALS
  • Private Grant  awarded by ACTELION CLINICAL RESEARCH, INC.
  • Private Grant  awarded by SCYNEXIS
  • Private Grant  awarded by ASTELLAS PHARMA US, INC.
  • Private Grant  awarded by SERES THERAPEUTICS INC.
  • Private Grant  awarded by IMMUNO-MYCOLOGICS, INC.
  • Private Grant  awarded by SERES THERAPEUTICS INC.
  • Private Grant  awarded by T2 BIOSYSTEMS
  • Private Grant  awarded by Gilead Sciences ^
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW
  • Private Grant  awarded by MERCK SHARP & DOHME CORP
  • Private Grant  awarded by SHIRE PHARMACEUTICALS DEVELOPMENT, INC.
  • Private Grant  awarded by SHIRE HUMAN GENETIC THERAPIES
  • Private Grant  awarded by SCYNEXIS
  • Private Grant  awarded by CRESTOVO LLC.
  • Private Grant  awarded by SERES THERAPEUTICS INC.
  • Private Grant  awarded by CONTRAFECT CORPORATION
  • Private Grant  awarded by SERES THERAPEUTICS INC.
  • Private Grant  awarded by MAYNE PHARMA INC
  • Private Grant  awarded by MERCK & COMPANY, INC. ^
  • Private Grant  awarded by VICAL, INC.
  • Private Grant  awarded by SYNEOS HEALTH
  • Private Grant  awarded by HOOKIPA BIOTECH
  • Private Grant  awarded by GENMARK DIAGNOSTICS
  • Private Grant  awarded by MERCK & COMPANY, INC. ^
  • Private Grant  awarded by CONTRAFECT CORPORATION
  • Private Grant  awarded by ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. - NEW
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW
  • Prospective Observational Evaluation of the Association between the Day 2 Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)  awarded by Duke University
  • The Natural History of Antifungal Failure in Invasive Candidiasis in the United States  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON)

    • Education And Training

  • UAB Hospital, Internship
  • UAB Hospital, Residency
  • UAB Hospital, Postdoctoral Fellowship
  • Doctor of Medicine, University of Alabama at Birmingham 2010
  • Bachelor of Science or Mathematics in Biology, University of Alabama at Birmingham 2005

    • Full Name

  • Todd McCarty